JK
Therapeutic Areas
CMTx Biotech Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Incyclinide | CBRN threat / Infectious disease (undisclosed) | Pre-clinical |
| CMTx R2 | Infectious diseases (host-directed treatment) | Pre-clinical |
| Drug | Indication | Phase |
|---|---|---|
| Incyclinide | CBRN threat / Infectious disease (undisclosed) | Pre-clinical |
| CMTx R2 | Infectious diseases (host-directed treatment) | Pre-clinical |